Jacksam Corporation Stocks

$ 0Last Updated 13.03.2026

Issuer Rating

3/7

Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 18744

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jacksam Corporation, a technology company, focuses on developing and commercializing products of vaporizer cartridge filling and capping, pre-roll filling, and automation systems. Its products include eShark cartridge filling machines, 710 Shark cartridge filling machines, 710 Captain cartridge capping machines, PreRoll-ER pre-roll and cone filling machines, and C-Cell cartridges. The company markets and sells its products to medical and recreational dispensaries, large and small-scale processors and growers, multi-state operators, and distributors through direct sales force, independent sales representatives, strategic partners' sales force, and a referral network, as well as its Website. It services the medical and recreational cannabis, hemp, and CBD segments of the e-cigarette, vaporizer, and pre-roll markets. The company was founded in 2013 and is based in Costa Mesa, California.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks